Leap Therapeutics, Inc. (LPTX) Cash Flow Annual - Discounting Cash Flows
LPTX
Leap Therapeutics, Inc.
LPTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing: 2025-05-13 2025-03-26 2024-03-18 2023-03-24 2022-03-11 2021-03-12 2020-03-16 2019-04-01 2018-02-23 2017-03-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31
Net Income/Starting Line -69.17 -67.56 -81.41 -54.6 -40.59 -27.51 -32.9 -23.14 -29.73 -25.63 -21.1 -25.45 -18.32 -7.76
Cash From Operating Activities -59.26 -60.3 -43.75 -49.04 -35.16 -25.96 -26.9 -26.03 -22.14 -25.34 -19.58 -18.02 -9.94 -7.55
Depreciation and Amortization 0 0.005 0.015 0.016 0.029 0.034 0.047 0.049 0.048 0.025 0.474 0.657 0.64 0.649
Deferred Income Tax 0 0 0 0.152 0.379 -0.738 -0.003 0.02 -0.158 0 0.37 -0.271 0.085 0.093
Stock Based Compensation 5.46 5.5 5.13 5.18 3.48 2.62 3.89 3.47 5.6 0.045 1.72 1.66 2.65 0.241
Other Non-Cash Items 3.9 0.457 30.01 0.855 0.527 0.634 0.732 -7.3 -0.194 1.23 0.014 4.54 4.45 -1.04
Changes in Working Capital 0.796 1.29 2.51 -0.651 1.01 -0.99 1.33 0.871 2.29 -1.01 -1.05 0.85 0.558 0.266
Accounts Receivable 0.247 0 1.3 -1.01 -1.16 0.117 0.643 0.78 1.46 -3.05 0 0 0.118 0
Inventory 0 0 0 1.01 1.16 -0.117 -0.643 0 0 0 0 0 0 0
Accounts Payable 2.92 0.902 0.712 0.945 3.9 -2.6 1.08 0.368 1.09 2.27 0 0 0 0
Deferred Revenue -2.74 0.388 0.497 -1.6 -2.89 1.61 0.247 0.503 1.2 -3.27 -1.05 0.85 0.44 0.266
Other Working Capital 0.373 0 0 0 0 0 0 -0.78 -1.46 3.05 0 0 0 0
Cash From Investing Activities 0 0 48.97 0 0 0.025 -0.085 0 -0.064 -0.144 29.69 -36.8 -0.114 -0.136
Investments in Property Plant and Equipment 0 0 0 0 0 0 -0.1 0 -0.064 -0.144 -0.012 -0.227 -0.116 -0.13
Payments for Acquisitions 0 0 50.36 0 0 0.025 0.015 0 0 0 0.061 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 -0.418 -35.39 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 30.05 0.053 0 0
Other Investing Activities 0 0 -1.39 0 0 0.025 0.015 0 -0.064 0 0.009 -1.24 0.002 -0.006
Cash From Financing Activities 37.09 37.18 -0.03 -0.21 98.03 74 14.82 15.91 47.76 25.62 0.016 46.89 13.75 12.29
Debt Repayment 0 0 0 0 0 0 0 0 0.75 25.9 4.4 0 0 0
Common Stock Issued -0.029 40 0 -0.21 97.22 48.52 15.25 15.03 49.16 -0.282 3.87 46.69 13.75 9.88
Common Stock Repurchased 0 0 -0.001 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 -0.234 0 0 0 -0.303 -0.359 0 0 0 0 0 0 0
Other Financing Activities 37.09 37.42 -0.029 -0.21 0.813 25.48 -0.437 0.872 -2.15 -0.282 -4.38 0.198 0 2.41
Effect of Forex Changes on Cash -0.039 -0.279 -0.043 -0.162 -0.033 0.115 -0.223 0.674 -0.618 0.251 -0.03 -0.193 -0.024 -0.004
Net Change in Cash -45.77 -23.39 5.14 -49.42 62.84 48.18 -12.39 -9.45 24.94 0.388 10.1 -8.13 3.67 4.6
Cash at Beginning of Period 78.48 70.64 65.5 114.9 52.07 3.89 16.28 25.74 0.793 0.405 10.87 19 15.32 10.72
Cash at End of Period 32.71 47.25 70.64 65.5 114.9 52.07 3.89 16.28 25.74 0.793 20.97 10.87 19 15.32
Free Cash Flow -59.26 -60.3 -43.75 -49.04 -35.16 -25.96 -27 -26.03 -22.2 -25.48 -19.59 -18.24 -10.05 -7.68
Operating Cash Flow -59.26 -60.3 -43.75 -49.04 -35.16 -25.96 -26.9 -26.03 -22.14 -25.34 -19.58 -18.02 -9.94 -7.55
Capital Expenditure 0 0 0 0 0 0 -0.1 0 -0.064 -0.144 -0.012 -0.227 -0.116 -0.13
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us